VKI has a total leverage of 39% The expense ratio is 3.44% and the non-leverage expense ratio is 0.96%. The fund's 6-month ...

Wall Street’s recent rally has propelled major U.S. stock benchmarks to record territory, with the S&P 500 (SP500) posting a ...

The Spot Solana ETF approval odds are at their peak, at 99% or higher, as the SEC acknowledges another filing. Here’s when it ...

The stock market is back where it started. The S&P 500 was down 0.3% after getting its head above water for a few gasps of air. The Nasdaq Composite was down 0.3%. The Dow was down 180 points, or 0.4% ...

The Orange Blossom Classic Committee officially launched the countdown to the 2025 Invesco QQQ Orange Blossom Classic with a ...

The biotechnology industry is split between two very different types of companies. On one side are the large, blue-chip leaders like Amgen Inc. (ticker: AMGN), Gilead Sciences Inc.

Invesco also bungled the messaging on its late 2018 purchase of OppenheimerFunds, which should have improved its organic AUM growth, realization rate, and profitability profiles. Instead, the firm's ...

The Invesco QQQ Trust is an index-tracking exchange-traded fund (ETF). The index it follows is the Nasdaq 100. They can ...

Invesco's (IVZ) preliminary assets under management rose 1.2% M/M to $2.025T at the end of July, it said on Monday.

Stocks are not the only means for generating gains and income - high yield debt CEFs can lock in yields before the next rate cut.